Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression"
- PMID: 33833094
- DOI: 10.1126/science.abf2022
Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression"
Abstract
Taniguchi et al (Research Articles, 17 July 2020, p. 269) claim that the cytokine interleukin-33 induces accumulation of tumor-associated macrophages expressing the immunoglobulin E receptor FcεRI. Although these findings hold great therapeutic promise, we provide evidence that the anti-FcεRI antibody used in this study is not specific for FcεRI on macrophages, which raises concerns about the validity of some of the conclusions.
Copyright © 2021, American Association for the Advancement of Science.
Comment in
-
Response to Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression".Science. 2021 Apr 9;372(6538):eabf3316. doi: 10.1126/science.abf3316. Science. 2021. PMID: 33833096
Comment on
-
Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression.Science. 2020 Jul 17;369(6501):eaay1813. doi: 10.1126/science.aay1813. Science. 2020. PMID: 32675345 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

